-
Statins and diabetes risk; new treatment guideline for diabetes; new pertussis vaccine recommendation; antibiotics and rhinosinusitis; fluoroquinolones and cystitis; and FDA actions.
-
The value of high sensitivity C-reactive protein (CRP) measurements in the management of patients at risk for cardiovascular (CV) events is controversial.
-
Although a routine part of a complete medical history, the value of systematically collecting family history has not been shown in controlled trials.
-
Timely recognition and treatment of myocardial infarction (MI) are crucial if we are to achieve optimal outcomes for our patients.
-
In patients with severe coronary artery disease (CAD) and depressed left ventricular (LV) function, coronary artery bypass graft (CABG) surgery remains the recommended treatment.
-
Beta-blockers have long been a cornerstone of therapy for patients who have suffered myocardial infarction (MI). However, most studies of beta blockade following MI were performed before the current era of reperfusion therapy, statins, and antiplatelet agents.
-
This paper reports the results of the Safety of Two Strategies of ICD Management at Implantation (SAFE-ICD) study.
-
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Current guidelines recommend cardiac rehabilitation using moderate exercise programs for most ischemic heart disease (IHD) patients. Also, studies have shown that the intensity of exercise is directly related to the cardioprotective effects.
-
The risks of noncardiac surgery after stent implantation are unclear, but have important implications for patient management.
